The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Join ShareProphets at less than 2p per article

> All the big AIM fraud exposés

> 300 articles and podcasts a month

> Hot share tips

> Original investigations by our experienced team

> No ads, no click-bait, no auto-play videos

Find out more

LAST 10 SEATS GOING: Meet & Quiz Nigel Wray, Sosandar, SkinBioTherapeutics and more on December 3rd: Book free seat now!

By Tom Winnifrith | Saturday 1 December 2018

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

There are now just ten seats left at the UK Investor Show team's next City forum which takes place on the evening of Monday 3rd December in the heart of the City of London at the headquarters of investment bank UBS. There’s mince pies, wine and canapes on offer but more importantly the event features presentations and a chance to quiz three growth companies: SkinBioTherapeutics, RiverFort Global Opportunities (formerly Paternoster Resources) and Sosandar. The evening ends with our own, Chris “Three Brains” Bailey, interviewing Britain's Buffett Nigel Wray.
The event starts at 5.30PM on Monday 3rd December with the talks commencing at 6PM. There will be a chance to chat to all the speakers in an informal session, with more drinks and canapes after the talks. Places are limited and there are now just ten seats left. To book your free seat click HERE

AIM listed fashion company Sosandar sees itself as the new destination for women’s clothing, fusing shopping with exclusive daily fashion news and style advice. Created by women, for women. Its shares have doubled since their IPO less than a year ago. 

SkinBioTherapeutics Plc is a life science company focused on skin health spun off by Optibiotix. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO, Prof. Cathy O’Neill and Prof. Andrew McBain.
RiverFort Global Opportunities gives AIM investors a unique way of getting exposure to the sort of structured finance many AIM companies utilise.
To discover what the excitement is about for these three companies and to hear Nigel and Chris in conversation, book your complimentary seats now. There are now just ten seats left To book your free seat click HERE
Best wishes
Tom Winnifrith

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.


Search ShareProphets |

Stock market news |

Complete Coverage

Recent Comments |

Site by Everywhen